Compare OPBK & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPBK | BDSX |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.7M | 162.8M |
| IPO Year | 2018 | 2020 |
| Metric | OPBK | BDSX |
|---|---|---|
| Price | $13.93 | $14.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $16.50 | ★ $32.50 |
| AVG Volume (30 Days) | 29.9K | ★ 76.0K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | ★ 23.74 | N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | $3,204,000.00 | ★ $88,499,000.00 |
| Revenue This Year | $16.07 | $25.26 |
| Revenue Next Year | $11.60 | $19.15 |
| P/E Ratio | $8.17 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $11.57 | $0.25 |
| 52 Week High | $15.27 | $20.21 |
| Indicator | OPBK | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 55.52 |
| Support Level | $13.66 | $12.77 |
| Resistance Level | $14.04 | $16.26 |
| Average True Range (ATR) | 0.36 | 1.16 |
| MACD | -0.10 | 0.53 |
| Stochastic Oscillator | 20.53 | 72.20 |
OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.